The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta-3-Adrenergic Receptor Agonists

Trial Profile

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta-3-Adrenergic Receptor Agonists

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2018

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Erectile dysfunction; Interstitial cystitis; Overactive bladder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Jun 2018 Preliminary data from healthy female volunteers (n=6) were presented at the 78th Annual Scientific Sessions of the American Diabetes Association.
    • 30 Dec 2017 Planned End Date changed from 31 Jul 2018 to 1 Oct 2021.
    • 13 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top